Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial

MSC in COVID-19 patients resulted safe and feasible, effectively modulating inflammatory cytokines, in particular mitigating brain damage related biomarker, suggesting both reduced inflammation and a potential neurological protection.

Authors

Institutions

Publication Details

Journal
Cytotherapy
Published
2025-04-08
DOI
https://doi.org/10.1016/j.jcyt.2025.04.059
Citations
1
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial

Giulia Bruzzi, Tommaso Zoerle, Elisa Pettorelli, Linda Manicardi et al.
1 citations
Cytotherapy
Long-Term Effects of COVID-19
1.39
article

Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial

Giulia Bruzzi, Tommaso Zoerle, Elisa Pettorelli, Linda Manicardi, Giorgio Mari, Elisa R. Zanier, Francesca Elice, Laura Pasetto, Filomena Pierri, Enrico Clini, Giuseppe Astori, Franco Bambi, Erica Dander, Maria Cristina Baschieri, Ilaria Lisi, Valentina Ruggieri, Massimo Dominici, Carlotta Spano, Olivia Candini, Daniela Catanzaro, Lorenza Lazzari, Roberto Tonelli, Valentina Bonetto, Anna Merlo, Rachele Ciccocioppo, Giulia Grisendi, M. Bernardi, Stefania Cerri, Giovanni Nattino, Pasquale Mighali, Anna Valeria Samarelli, Francesca Pischiutta, Giovanna D’Amico, Michela Maur, Simona Guidi, Fabiola Signorini, Laura Fiammenghi, Laura Boschi, Giorgia De Berardis
article en
1 citations

Abstract

MSC in COVID-19 patients resulted safe and feasible, effectively modulating inflammatory cytokines, in particular mitigating brain damage related biomarker, suggesting both reduced inflammation and a potential neurological protection.

CytotherapyVol. 27(9)
University of Verona (IT), University of Modena and Reggio Emilia (IT), Mario Negri Institute for Pharmacological Research (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda Unita' Sanitaria Locale Di Modena (IT), ProQR Therapeutics (Netherlands) (NL), Azienda Ospedaliero-Universitaria di Modena (IT), Azienda Ospedaliera San Gerardo (IT), Meyer Children's Hospital (IT), Ospedale Santa Maria (IT), Ospedale Santa Maria della Misericordia di Udine (IT), Ospedale di Mirano (IT), Hesperia Hospital (IT), Ospedale San Bortolo (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Center for Outcomes Research and Clinical Epidemiology (IT)
Zero hunger
Openalex Percentile: Top 21%
Long-Term Effects of COVID-19
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.